Effect of Sertraline Tablets Combined with Cognitive Behavior Therapy on Adolescent Depression
Objective Explore the value of combining Shequlin tablets with cognitive-behavioral therapy in the treatment of adolescent depression patients,and analyze the impact of this program on multiple indicators such as cognition and sleep.Methods A total of 110 adolescent patients diagnosed with depression from January 2021 to December 2022 were randomly divided into two groups using an Excel spreadsheet.One group received treatment with sertraline hydrochloride(control),while the other group received treatment with sertraline hydrochloride and cognitive-behavioral therapy(observation).Compare the clinical efficacy of treating two groups of patients and assess their cognitive function,sleep status,suicidal ideation,and depression scores before and after treatment.Results Compared with the control group,the clinical efficacy of the observation group of 55 patients increased after treatment(P<0.05).The observation group showed an increase in the scores of the Montreal Cognitive Assessment Scale at 1,2,and 6 weeks after treatment(P<0.05).The observation group showed a decrease in Pittsburgh Sleep Quality In-dex scores at 1,2,and 6 weeks after treatment(P<0.05).The suicide attitude assessment scores of the observation group increased significantly at 1 week,2 weeks,and 6 weeks after treatment(P<0.05).The Hamilton Depression Scale-17 score in the observation group was lower than that in the control group(P<0.05).Conclusion Choosing the combination of Shequlin tablets and cognitive-behavioral therapy in the treatment of adolescent depression can better improve their cognitive function,alleviate the impact of depressive symptoms on patients'sleep quality,and avoid their own thoughts affecting their own safety and social security.